CML is my second cancer. I too want to know all of the risks and potential side effects, especially as more TKIs, and therefore more choices, become available. My medical team and I balance multiple considerations, and need data to do so. We have already had to address the potential risk of increasing the chance of a recurrence of the first cancer while considering changing my TKI. This involved two "expert" opinions, one of which was inaccurate. Fortunately we were able to consult with a third expert, one who is only focused on CML, and get the data we needed to make the right choices. Separately, I feel very strongly that patients with any type of cancer deserve to know the full risks they face from their treatments, including the risk of developing blood cancers down the road, so they can make informed choices, be aware of the potential warning signs, and optimize their chances for recovery.
Pat Elliott Phoenix, Arizona -- [CMLHope] A support group of http://cmlhope.com ------------------------------------------------- You received this message because you are subscribed to the Google Groups "CMLHope" group. To post to this group, send email to [email protected] To unsubscribe from this group, send email to [email protected] For more options, visit this group at http://groups.google.com/group/CMLHope
